NOF CORP

Overview

NOF CORP is an active pharmaceutical ingredient (API) supplier with 36 active FDA Type II Drug Master Files, covering (N-(METHOXYPOLYETHYLENEGLYCOLCARBAMOYL)-1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHATIDYL-ETHANOLAMINE,MONOSODIUM SALT); 1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHYLPOLYOXYETHYLENE (MW 2,000); 2,3-BIS(METHYLPOLYOXYETHYLENE-OXY)-1-(SUCCINIMIDYLOXY CARBONYLOXY) PROPANE (MW: 40,000); 2,3-BIS(METHYLPOLYOXYETHYLENE-OXY)-1-{[3-(3-MALEIMIDO-1-OXOPROPYL)AMINO]PROPYLOXY} PROPANE (MW 60,000); a- METHOXY-w -(4-NITROPHENOXY CARBONYL), POLYOXYETHYLENE MW 10000; A-(3-OXOPROPYL)-W-(3-OXOPROPOXY),POLYOXYETHYLENE (MW 3400).

API / Drug Master Files

NOF CORP holds 36 active (40 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• 2,3-BIS(METHYLPOLYOXYETHYLENE-OXY)-1-(SUCCINIMIDYLOXY CARBONYLOXY) PROPANE (MW: 40,000)Active2022-10-28
• POLY(OXY-1,2-ETHANEDIYL), A-METHYL- W-{2-[(2,5-DIOXO-1-PYRROLIDINYL)OXY]-2-OXOETHOXY}-(MW: 5,000)Active2022-01-12
• a-[3-(3-MALEIMIDO-1-OXOPROPYL)AMINO]PROPYL-W-METHOXY, POLYOXYETHYLENE (MW 40,000)Active2021-06-28
• A-2-[(6-MALEIMIDO-1-OXOHEXYL)AMINO]ETHYL-W-METHOXY, POLYOXYETHYLENE (MW 20,000)Active2021-03-02
• A-(3-OXOPROPYL)-W-(3-OXOPROPOXY),POLYOXYETHYLENE (MW 3400)Active2021-01-12
• 1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHYLPOLYOXYETHYLENE (MW 2,000)Active2020-12-10
• Á-METHYL-W-(3-OXOPROPOXY), POLYOXYETHYLENE (MW 5,000)Active2018-03-23
• a-SUCCINIMIDYLOXYGLUTARYL-w-METHOXY, POLYOXYETHYLENE (MW 5,000)Active2017-11-06
• 2,3-BIS(METHYLPOLYOXYETHYLENE-OXY)-1-{[3-(3-MALEIMIDO-1-OXOPROPYL)AMINO]PROPYLOXY} PROPANE (MW 60,000)Active2016-08-24
• ALPHA-METHYL-OMEGA-(3-OXOPROPOXY), POLYOXYETHYLENE (MW 20,000)Active2015-06-30
• ALPHA-[3-(3-MALEIMIDO-1-OXOPROPYL)AMINO]PROPYL-OMEGA-METHOXY, POLYOXYETHYLENEActive2015-04-27
• POLY(OXY-1,2-ETHANEDIYL), ALPHA-METHYL -OMEGA-{6-[(2,5-DIOXO-1 -PYRROLIDINYL)OXY]-6-OXOHEXYLOXY}Active2014-11-26
• ALPHA-(3'-{[1,2-DI(MYRISTYLOXY)PROPANOXY]CARBONYLAMINO}PROPYL)-OMEGA-METHOXY, POLYOXYETHYLENEActive2014-09-26
• (N-(METHOXYPOLYETHYLENEGLYCOLCARBAMOYL)-1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHATIDYL-ETHANOLAMINE,MONOSODIUM SALT)Active2014-05-01
• ALPHA-SUCCINIMIDYLOXYSUCCINYL-OMEGA-METHOXY, POLYOXYETHYLENE MW: 4,500Active2013-10-01

Showing 15 of 40 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NOF CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.